Etiology and Epidemiological Features
The causative agent of the disease is the Hepatitis E virus (HEV). Structurally, its genome consists of a single strand of RNA. In modern virological classification, it is categorized as an unclassified virus, although in earlier sources it was typically included in the family Caliciviridae.
The only reservoir of infection in nature is humans with acute Hepatitis E. The transmission mechanism is strictly fecal-oral. It is important to note that parenteral, vector-borne, or airborne transmission routes are not characteristic of this pathogen.
The leading route of transmission is waterborne: infection occurs through the consumption of unsafe drinking water or contact with contaminated open water bodies. The epidemiological pattern shows an extremely uneven global distribution of incidence. Endemic regions are typified by mass outbreaks and large epidemics. At the same time, non-endemic areas register only rare sporadic cases, which are usually imported. Susceptibility to the virus is universal, but clinically apparent forms are statistically most frequent in young adults aged 15 to 29 years.
Pathogenesis and Clinical Manifestations
To date, the pathogenesis of Hepatitis E is not fully understood. It is believed that the primary mechanism of liver tissue damage is the direct cytopathic effect of the virus itself on hepatocytes. In addition, researchers suggest the potential involvement of immune-mediated mechanisms in destroying infected cells.
Clinical manifestations share many features with Hepatitis A. In clinical practice, several forms of the infection are distinguished: manifest (which can occur in either icteric or anicteric variants) and asymptomatic.
The dynamics of a typical manifest form include several stages:
- Incubation period: varies widely from 15 to 60 days.
- Prodromal period: lasts from 1 to 10 days, preceding specific symptoms.
- Icteric period: is brief and usually takes no more than 15 days.
During the first week of the manifest stage, symptoms such as jaundice, dull pain in the right upper quadrant, and clinical-laboratory signs of cholestasis syndrome come to the forefront. In the vast majority of cases, the disease has a mild course. Resolution of the process, including the regression of all symptoms and full recovery of the patient, occurs 2 to 4 weeks after disease onset.
Outcomes and High-Risk Groups
A crucial feature of Hepatitis E is that chronicity is not characteristic of this infectious process. The disease occurs exclusively in an acute form. The overall population mortality rate remains relatively low, ranging from 0.5% to 3%.
Nevertheless, specific high-risk groups face extreme danger upon exposure to the virus due to a severely complicated course:
- Pregnant women. The infection poses the greatest threat when contracted during the second and third trimesters of pregnancy. During this period, the disease frequently assumes a fulminant course. The mortality rate in this group is catastrophically high, reaching 20%.
- Patients with underlying liver pathology. Pre-existing chronic viral hepatitis B or C significantly complicates the course of Hepatitis E and worsens the overall prognosis.